Description
Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. MK-677 (Ibutamoren) is not approved for medical use, human consumption, or as a therapeutic treatment in this context.
Product Details
- Dosage: 12.5mg per capsule
- Quantity: 60 capsules per container
- Form: Oral research capsules
- Packaging: Secure, sealed, tamper-evident bottle
- Source: High-purity laboratory-grade compound, independently third-party tested
- Purity: ≥99% verified via analytical testing
- Note: Intended strictly for controlled laboratory and experimental research applications
Overview of MK-677’s Research Profile
MK-677 (Ibutamoren) is a non-peptide growth hormone secretagogue studied for its ability to mimic ghrelin and activate the growth hormone secretagogue receptor (GHS-R1a). Unlike peptide-based secretagogues, MK-677 is orally bioavailable and exhibits a prolonged activity profile, making it a valuable compound for research into sustained endocrine signaling and long-duration receptor activation.
In laboratory environments, MK-677 is utilized to investigate growth hormone and IGF-1 pathway dynamics, ghrelin receptor signaling, and metabolic feedback systems. Its extended half-life allows researchers to model continuous receptor engagement and analyze downstream signaling over extended periods.
Research Specifics
MK-677 has been examined in non-clinical research for its involvement in:
- Ghrelin Receptor Activation
Studying binding and activation of GHS-R1a and associated intracellular signaling cascades.
- Growth Hormone & IGF-1 Axis Research
Modeling sustained stimulation of GH release and downstream IGF-1 signaling pathways.
- Endocrine Feedback Loop Analysis
Evaluating long-duration hormonal signaling and regulatory feedback mechanisms.
- Metabolic Pathway Studies
Investigating interactions between ghrelin signaling, nutrient sensing, and energy balance.
- Oral Bioavailability & Stability Research
Examining non-peptide compound stability and absorption modeling in capsule form.
Key Features
- Compound Class: Non-peptide growth hormone secretagogue
- Receptor Target: GHS-R1a (ghrelin receptor)
- Form: Oral capsule formulation
- Dosage: 12.5mg per capsule
- Purity: ≥99% research-grade
- Laboratory Stability: Highly stable under standard dry-storage conditions
Potential Applications
Researchers may explore MK-677 in studies involving:
- Growth hormone and IGF-1 signaling pathways
- Ghrelin receptor activation and modulation
- Endocrine system feedback regulation
- Long-duration receptor signaling models
- Oral compound pharmacokinetics and stability
Specifications
This product is supplied in a sealed, tamper-evident container to preserve compound integrity and purity. Capsules should be stored in a cool, dry environment according to standard laboratory handling protocols for oral research compounds.
Reviews
There are no reviews yet.